193 related articles for article (PubMed ID: 4379140)
21. Pharmacotherapeutical census in a psychiatric hospital (comparison with the year 1966).
Topiar A; Stevková K; Rampácek J
Act Nerv Super (Praha); 1972; 14(2):81. PubMed ID: 5040170
[No Abstract] [Full Text] [Related]
22. A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.
Douglas KW; Hindley JP
J Clin Pharmacol J New Drugs; 1969; 9(3):176-82. PubMed ID: 4892453
[No Abstract] [Full Text] [Related]
23. [Effect of psychotropic drugs on cholinesterase activity in blood serum of mental patients].
Pietruszewska I; Urbanek B
Acta Pol Pharm; 1968; 25(2):201-6. PubMed ID: 5662912
[No Abstract] [Full Text] [Related]
24. [Progress in therapy. A remedy for character disorders].
Rass Int Clin Ter; 1966 Jun; 46(11):615. PubMed ID: 4383987
[No Abstract] [Full Text] [Related]
25. Pericyazine in clinical practice.
Jenner FA
Laval Med; 1970 Jun; 41(6):796-804. PubMed ID: 5509701
[No Abstract] [Full Text] [Related]
26. factors influencing response to major tranquilizer medications.
Kimbell I; Overall JE; Faibish GM; Pokorny AD
Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
[No Abstract] [Full Text] [Related]
27. Mesoridazine (Serentil).
Med Lett Drugs Ther; 1971 Jan; 13(1):4. PubMed ID: 5560077
[No Abstract] [Full Text] [Related]
28. Evaluation of prochlorperazine and a prochlorperazine-chlorpromazine combination in disturbed patients.
NOBLE RC; CASTNER CW
Dis Nerv Syst; 1958 Dec; 19(12):531-3. PubMed ID: 13609506
[No Abstract] [Full Text] [Related]
29. Treatment of psychiatric inpatients with mesoridazine.
Krout BM; Stone CB
Psychosomatics; 1969; 10(4):244-8. PubMed ID: 5808616
[No Abstract] [Full Text] [Related]
30. Evaluation of tranquillisers with subnormal patients. 2. Pericyazine and chlorpromazine.
MacKay DN
Nurs Mirror Midwives J; 1971 Aug; 133(6):32-3. PubMed ID: 5208961
[No Abstract] [Full Text] [Related]
31. [Clinical study of oxaflumazine; its place among the neuroleptics].
Deniker P; Ginestet D; Peron-Magnan P; Colonna L; Loo H
Therapie; 1971; 26(1):227-33. PubMed ID: 5554766
[No Abstract] [Full Text] [Related]
32. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
Tetreault L
Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
[No Abstract] [Full Text] [Related]
33. The effectiveness of a new drug, mesoridazine, and chlorpromazine with behavior problems in children.
Kenny TJ; Badie D; Baldwin RW
J Nerv Ment Dis; 1968 Sep; 147(3):316-21. PubMed ID: 4878442
[No Abstract] [Full Text] [Related]
34. Clinical experience with piperacetazine in hospitalized mental patients. A four year study.
Ralston JD; Abreu BE
J Indiana State Med Assoc; 1970 Nov; 63(11):1291-6. PubMed ID: 5495472
[No Abstract] [Full Text] [Related]
35. Psychotropic drugs in old age.
Birkett DP; Boltuch B
J Med Soc N J; 1973 Sep; 70(9):647-8. PubMed ID: 4518003
[No Abstract] [Full Text] [Related]
36. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
37. [Clinical experiences with the neuroleptic butyryl-perazine (Wu 2791-AWD). Contribution to the syndromatic concept of endogenous psychoses].
Kühne GE; Rennert H
Z Arztl Fortbild (Jena); 1965 Feb; 59(3):140-6. PubMed ID: 5885796
[No Abstract] [Full Text] [Related]
38. [Clinical expressions of aggressive behavior and their treatment].
Montanini R; Mastruzzo A; Giovannucci M
G Psichiatr Neuropatol; 1968; 96(3):567-76. PubMed ID: 4389866
[No Abstract] [Full Text] [Related]
39. The use of pericyazine and chlorpromazine with disturbed mentally subnormal patients.
Weir TW; Kernohan GA; MacKay DN
Br J Psychiatry; 1968 Jan; 114(506):111-2. PubMed ID: 4865742
[No Abstract] [Full Text] [Related]
40. A clinical trial with mesoridazine (another phenodiazine derivative).
Rudy L; Marozas RJ; Sykes D; Smith JA
Dis Nerv Syst; 1968 Jun; 29(6):412-3. PubMed ID: 4877749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
